85 related articles for article (PubMed ID: 11522623)
21. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line.
Maeda O; Usami N; Kondo M; Takahashi M; Goto H; Shimokata K; Kusugami K; Sekido Y
Oncogene; 2004 Jan; 23(4):964-72. PubMed ID: 14661054
[TBL] [Abstract][Full Text] [Related]
22. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
Takahashi M; Nakamura Y; Obama K; Furukawa Y
Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
[TBL] [Abstract][Full Text] [Related]
23. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers.
Takahashi M; Tsunoda T; Seiki M; Nakamura Y; Furukawa Y
Oncogene; 2002 Aug; 21(38):5861-7. PubMed ID: 12185585
[TBL] [Abstract][Full Text] [Related]
24. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
Esufali S; Bapat B
Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
[TBL] [Abstract][Full Text] [Related]
25. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis.
Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC
Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908
[TBL] [Abstract][Full Text] [Related]
26. Ligand-dependent inhibition of beta-catenin/TCF signaling by androgen receptor.
Chesire DR; Isaacs WB
Oncogene; 2002 Dec; 21(55):8453-69. PubMed ID: 12466965
[TBL] [Abstract][Full Text] [Related]
27. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.
Chung GG; Provost E; Kielhorn EP; Charette LA; Smith BL; Rimm DL
Clin Cancer Res; 2001 Dec; 7(12):4013-20. PubMed ID: 11751495
[TBL] [Abstract][Full Text] [Related]
28. Target disruption of the mutant beta-catenin gene in colon cancer cell line HCT116: preservation of its malignant phenotype.
Sekine S; Shibata T; Sakamoto M; Hirohashi S
Oncogene; 2002 Aug; 21(38):5906-11. PubMed ID: 12185590
[TBL] [Abstract][Full Text] [Related]
29. Construction of preferential cDNA microarray specialized for human colorectal carcinoma: molecular sketch of colorectal cancer.
Takemasa I; Higuchi H; Yamamoto H; Sekimoto M; Tomita N; Nakamori S; Matoba R; Monden M; Matsubara K
Biochem Biophys Res Commun; 2001 Aug; 285(5):1244-9. PubMed ID: 11478790
[TBL] [Abstract][Full Text] [Related]
30. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.
Liu W; Dong X; Mai M; Seelan RS; Taniguchi K; Krishnadath KK; Halling KC; Cunningham JM; Boardman LA; Qian C; Christensen E; Schmidt SS; Roche PC; Smith DI; Thibodeau SN
Nat Genet; 2000 Oct; 26(2):146-7. PubMed ID: 11017067
[No Abstract] [Full Text] [Related]
31. Overexpression of the beta-catenin binding domain of cadherin selectively kills colorectal cancer cells.
Pierce M; Wang C; Stump M; Kamb A
Int J Cancer; 2003 Nov; 107(2):229-37. PubMed ID: 12949799
[TBL] [Abstract][Full Text] [Related]
32. Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor.
Widlund HR; Horstmann MA; Price ER; Cui J; Lessnick SL; Wu M; He X; Fisher DE
J Cell Biol; 2002 Sep; 158(6):1079-87. PubMed ID: 12235125
[TBL] [Abstract][Full Text] [Related]
33. Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers.
Miwa N; Furuse M; Tsukita S; Niikawa N; Nakamura Y; Furukawa Y
Oncol Res; 2001; 12(11-12):469-76. PubMed ID: 11939410
[TBL] [Abstract][Full Text] [Related]
34. S100A6 is transcriptionally regulated by β-catenin and interacts with a novel target, lamin A/C, in colorectal cancer cells.
Kilańczyk E; Graczyk A; Ostrowska H; Kasacka I; Leśniak W; Filipek A
Cell Calcium; 2012 Jun; 51(6):470-7. PubMed ID: 22560296
[TBL] [Abstract][Full Text] [Related]
35. Isolation and characterization of human NBL4, a gene involved in the beta-catenin/tcf signaling pathway.
Ishiguro H; Furukawa Y; Daigo Y; Miyoshi Y; Nagasawa Y; Nishiwaki T; Kawasoe T; Fujita M; Satoh S; Miwa N; Fujii Y; Nakamura Y
Jpn J Cancer Res; 2000 Jun; 91(6):597-603. PubMed ID: 10874211
[TBL] [Abstract][Full Text] [Related]
36. Few point mutations in elongation factor-1gamma gene in gastrointestinal carcinoma.
Frazier ML; Inamdar N; Alvula S; Wu E; Kim YH
Mol Carcinog; 1998 May; 22(1):9-15. PubMed ID: 9609096
[TBL] [Abstract][Full Text] [Related]
37. Protein shuttles, IGF-I and colorectal cancer.
Bustin S
Trends Mol Med; 2001 Jan; 7(1):9. PubMed ID: 11427994
[No Abstract] [Full Text] [Related]
38. Analysis of the beta-catenin/T cell factor signaling pathway in 36 gastrointestinal and liver cancer cells.
Ikenoue T; Ijichi H; Kato N; Kanai F; Masaki T; Rengifo W; Okamoto M; Matsumura M; Kawabe T; Shiratori Y; Omata M
Jpn J Cancer Res; 2002 Nov; 93(11):1213-20. PubMed ID: 12460462
[TBL] [Abstract][Full Text] [Related]
39. Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells.
Kim JS; Crooks H; Dracheva T; Nishanian TG; Singh B; Jen J; Waldman T
Cancer Res; 2002 May; 62(10):2744-8. PubMed ID: 12019147
[TBL] [Abstract][Full Text] [Related]
40. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB.
Batlle E; Henderson JT; Beghtel H; van den Born MM; Sancho E; Huls G; Meeldijk J; Robertson J; van de Wetering M; Pawson T; Clevers H
Cell; 2002 Oct; 111(2):251-63. PubMed ID: 12408869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
